×
ADVERTISEMENT

Monographs & Whitepapers

OCTOBER 10, 2024

RAAS Dysfunction and Angiotensin II for Management of Post-Cardiopulmonary Bypass Vasoplegia

This article describes the pathophysiology of post-cardiopulmonary bypass vasoplegia, the effects of renin-angiotensin-aldosterone system dysfunction, and the use of angiotensin II as an efficacious, safe, and evidence-based therapeutic intervention.

Download to read this article in PDF format:

Pdf RAAS Dysfunction and Angiotensin II for Management of Post-Cardiopulmonary Bypass Vasoplegia

This article is in PDF format and it requires Adobe Reader. If you do not have Adobe Reader installed on your computer then please download and install from the link below.

Acrobat Reader Download Adobe Reader

Related Keywords
cardiac surgery   angiotensin   cardiopulmonary bypass   vasodilatory shock   renin–angiotensin system   angiotensin receptor blocker   ACE Inhibitors   vasopressin   vasoplegia   RAAS pathways   catecholamine